Having ascertained that the intraductal microenvironment preserves the distinct biological characteristics of ILC versus non‐lobular ER+, HER2− BC cells, we sought to determine the molecular underpinnings of these differences using patient‐derived carcinoma cells. This evidence concerns the gene ERBB2 and carcinoma.